LNB News 11/12/2024
Document Information
Issue Date: 11 December 2024
Published Date: 11 December 2024
Jurisdiction(s): European Union
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has published its 2024 pipeline review, revealing significant progress in pharmaceutical innovation. The report indicates that the European Medicines Agency has issued 97 new market authorisations this year, including 56 new active substances. Oncology continues to dominate clinical research, accounting for 29% of trials. The review also highlights advancements in antimicrobial resistance vaccines, mRNA vaccines for cancer treatment, novel therapies for major depressive disorder and gene therapies for rare diseases. However, the report underscores the urgent need for incentives to bolster antimicrobial development, with only four innovative antimicrobials currently in the pipeline. EFPIA emphasises the importance of supportive policies and collaborative approaches to sustain Europe's health security and innovation capabilities.
To continue reading this news article, as well as thousands of others like it, sign in with UUÂãÁÄÖ±²¥ or register for a free trial
EXISTING USER? SIGN IN CONTINUE READING GET A QUOTE
To read the full news article, register for a free Lexis+ trial
**Trials are provided to all UUÂãÁÄÖ±²¥ content, excluding Practice Compliance, Practice Management and Risk and Compliance, subscription packages are tailored to your specific needs. To discuss trialling these UUÂãÁÄÖ±²¥ services please email customer service via our online form. Free trials are only available to individuals based in the UK, Ireland and selected UK overseas territories and Caribbean countries. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
* denotes a required field
If planning permission imposes restrictions on a licensed premises opening hours, once operational can the personal licence holder apply for a Temporary Events Notice (TEN) to open for longer hours than those permitted in the planning permission?To use any property for a licensable activity both
Micklefield clausesWhat is a Micklefield clause?It is common for employee share plans to provide that, on termination of employment (or when an employee is given or receives notice of termination of employment), subsisting share awards will be forfeited and subsisting share options will lapse.It is
Financial clean break orders in family proceedingsDuty of the court to consider a clean breakAlthough there is no presumption in favour of there being a financial clean break between parties on divorce, the court is under a duty to consider whether it would be appropriate to exercise its powers so
Brussels I (recast)—domicile (Arts 4 and 63) [Archived]ARCHIVED: This Practice Note has been archived and is not maintained.This Practice Note considers the general rule set out in Article 4 of Regulation (EU) 1215/2012, Brussels I (recast) when determining the relevance of a defendant’s domicile to
0330 161 1234